Last Updated: November 8, 2026

CEFEPIME IN PLASTIC CONTAINER Drug Patent Profile

« Back to Dashboard


Which patents cover Cefepime In Plastic Container, and when can generic versions of Cefepime In Plastic Container launch?

Cefepime In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in CEFEPIME IN PLASTIC CONTAINER is cefepime hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime In Plastic Container

A generic version of CEFEPIME IN PLASTIC CONTAINER was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CEFEPIME IN PLASTIC CONTAINER?
  • What are the global sales for CEFEPIME IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CEFEPIME IN PLASTIC CONTAINER?
Summary for CEFEPIME IN PLASTIC CONTAINER
Recent Clinical Trials for CEFEPIME IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of PennsylvaniaPHASE4
National Institute of Allergy and Infectious Diseases (NIAID)PHASE4
WockhardtPHASE1

See all CEFEPIME IN PLASTIC CONTAINER clinical trials

Pharmacology for CEFEPIME IN PLASTIC CONTAINER

US Patents and Regulatory Information for CEFEPIME IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEFEPIME IN PLASTIC CONTAINER cefepime hydrochloride INJECTABLE;INJECTION 050817-001 Aug 5, 2008 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare CEFEPIME IN PLASTIC CONTAINER cefepime hydrochloride INJECTABLE;INJECTION 050817-002 Aug 5, 2008 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.